HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

A cohort study examines whether the use of common medications was associated with worse outcomes in patients with lung cancer taking immunotherapy.

Nasal drops eliminated the deadliest brain cancer in mice and activated long-lasting immune defenses that prevented the return of tumors ...

Brain metastases are far from a niche concern; with 100,000 to 200,000 cases diagnosed annually in the US, the scale of the ...

Finge medical groups once touted ivermectin as an effective COVID-19 treatment. But studies did not find that to be true, and there's no new evidence to suggest it can fight cancer, either.

The U.S. FDA has granted orphan drug designation to HCB101, an investigational immunotherapy, for the treatment of gastric cancer.

NovoCure (NVCR) stock rose 29% Thursday on early FDA approval for Optune Pax pancreatic cancer device, prompting H.C. Wainwright to raise target to $47.

Sarasota Memorial has joined an international study exploring a new treatment for skin cancer. SMH’S Kolschowsky Research and Education Institute is part of an ...

Nearly 70% of cancer drugs granted FDA accelerated approval between 2011 and 2020 required safety updates within 4 years.“Postmarketing safety actions are common,” Maryam Mooghali, MD, MSc, internal ...

Patients with one of the deadliest gynecological cancers had dramatically improved survival when an experimental drug was added to treatment with a standard chemotherapy medication in a mid-stage ...

A first-of-its-kind device for pancreatic cancer treatment has been approved by the U.S. Food and Drug Administration.